BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//TB Elimination Alliance - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TB Elimination Alliance
X-ORIGINAL-URL:https://tbeliminationalliance.org
X-WR-CALDESC:Events for TB Elimination Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210804T120000
DTEND;TZID=America/Los_Angeles:20210804T130000
DTSTAMP:20210806T182700Z
CREATED:20210707T201430Z
LAST-MODIFIED:20210806T182700Z
UID:486-1628078400-1628082000@tbeliminationalliance.org
SUMMARY:Webinar: "Addressing Latent Tuberculosis Infection and Tuberculosis in Asian and Native Hawaiian/Pacific Islander Communities: The Role of Health Centers for Testing and Treatment"
DESCRIPTION:Join us with Tenzin Kunor from We Are TB and Dr. Sheldon Riklon from UAMS Health Family Medical Center in Fayetteville\, AR and Community Clinic in Northwest Arkansas to learn more about a TB survivor’s experience\, and the role of community health centers around latent tuberculosis infection (LTBI) and tuberculosis (TB) disease testing and treatment. \nIn 2019\, a total of 8\,916 TB disease cases were reported in the United States and its Territories. Out of those cases\, TB disease was reported in 3\,150 Asians. Asians and Native Hawaiians/Pacific Islanders are disproportionately impacted by TB at a greater rate compared to other racial and ethnic groups. For example\, the rate of TB disease is 32 times higher for Asians than whites. Considering the complex health and social needs of the Asian and Native Hawaiian/Pacific Islander communities\, health centers play a critical role as a safety net provider and community partner to address special and vulnerable populations with increased risk of TB. \nThis webinar will share a patient survivor experience with TB; discuss successful strategies for chronic disease management and LTBI/TB screening\, testing\, and treatment in high need populations in community health care settings; and share information about the TB Elimination Alliance initiative. \nLearning Objectives: \n\nDevelop an understanding of a patient survivor’s experience with TB and addressing TB-related stigma\nDiscuss successful strategies for chronic disease management and LTBI/TB screening\, testing\, and treatment in high need populations in community health care settings\nLearn about the TB Elimination Alliance initiative and training opportunities for community health centers and community-based organizations\n\nIntended Audience:  \nHealth centers\, community-based organizations\, public health departments\, Primary Care Associations (PCAs)\, Health Center Controlled Networks (HCCN)\, and organizations interested and/or invested in TB elimination and LTBI treatment among at-risk communities. \nWebinar Resources:  \n\nWebinar Slides \nWebinar Recording
URL:https://tbeliminationalliance.org/event/addressing-latent-tuberculosis-infection-and-tuberculosis-in-asian-native-hawaiian-and-pacific-islander-communities-the-role-of-health-centers-for-testing-and-treatment/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/png:https://tbeliminationalliance.org/wp-content/uploads/2021/07/Zoom-Banner-TB-Webinar-8.4.21-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220120T130000
DTEND;TZID=America/Los_Angeles:20220120T150000
DTSTAMP:20220121T164421Z
CREATED:20211216T162007Z
LAST-MODIFIED:20220121T164421Z
UID:848-1642683600-1642690800@tbeliminationalliance.org
SUMMARY:"A Conversation with CDC Partners" Webinar
DESCRIPTION:Hep B United/Tuberculosis Elimination Alliance Summit \n“A Conversation with CDC Partners” Webinar\nThursday\, January 20\, 2022 | 11:00am HT / 1:00pm PT / 4:00pm ET \nHep B United and the Tuberculosis (TB) Elimination Alliance hosted “A Conversation with CDC Partners” webinar on January 20\, 2022. Originally a part of the 2021 Hep B United / TB Elimination Alliance Summit\, this webinar session was an opportunity to engage with leaders and partners from across the nation to discuss and collaborate on hepatitis B and TB elimination efforts.  \nDr. Noele Nelson and Dr. Philip LoBue from the CDC discussed the challenges and opportunities to eliminate hepatitis B and TB and advance health equity. \nLearning Objectives:  \n\nIdentify current trends with hepatitis B and TB;\nLearn about CDC center wide collaboration opportunities and joint priorities; and\nLearn about how COVID-19 has affected CDC’s priorities to eliminate hepatitis B and TB. \n\nIntended Participants: Providers at community health organizations interested and/or invested in hepatitis B and/or TB/LTBI testing and treatment.  \nFee: No cost/free \n\nModerator and Introductions \nJoe Lee\, MSHA\, Director of Strategic Initiatives and Partnerships\, Association of Asian Pacific Community Health Organizations \nKate Moraras\, MPH\, Deputy Director of Public Health\, Hepatitis B Foundation and Director of Hep B United \nOpening Remarks  \nJonathan Mermin\, MD\, MPH\, Director of the National Center for HIV\, Viral Hepatitis\, STD\, and TB Prevention\, Centers for Disease Control and Prevention \nJonathan Mermin\, MD\, MPH\, is Director of the National Center for HIV\, Viral Hepatitis\, STD\, and TB Prevention at CDC. Previously\, he was Director of the Division of HIV/AIDS Prevention at CDC\, Director of CDC-Kenya\, and Director of CDC-Uganda. He has focused his public health career on science-based\, practical programs that increase health equity and decrease incidence and mortality. Dr. Mermin was an internal medicine resident at San Francisco General Hospital\, and a preventive medicine resident at CDC and the California Department of Health Services. He is a graduate of Harvard College and Stanford University School of Medicine\, and received his MPH from Emory University. He is a Rear Admiral in the U.S. Public Health Service.\n \nFeatured Speakers \nNoele P. Nelson\, MD\, PhD\, MPH\, Chief of Prevention Branch\, Division of Viral Hepatitis\, Centers for Disease Control and Prevention \nDr. Noele Nelson is a Pediatrician\, and she holds a doctorate in Epidemiology. She joined the CDC/Division of Viral Hepatitis nine years ago and currently serves as the Chief of the Prevention Branch. In this role she oversees national efforts to test\, implement and monitor hepatitis B and C care and cure cascades\, perinatal hepatitis B and C prevention projects and viral hepatitis guideline development. Dr. Nelson focuses on hepatitis A and B vaccine research and policy and serves on the CDC Advisory Committee on Immunization Practices Steering Committee. She also has a strong interest in emergency response and has served on numerous CDC responses. \nPhilip LoBue\, MD\, FACP\, FCCP\, Director of Division of Tuberculosis Elimination\, Centers for Disease Control and Prevention \nPhilip LoBue is the Director of the Division of Tuberculosis Elimination (DTBE) in CDC’s National Center for HIV\, Viral Hepatitis\, STD\, and TB Prevention. Dr. LoBue received his undergraduate and medical degrees from the University of Pennsylvania. He received postgraduate training in Internal Medicine and Pulmonary and Critical Care Medicine at the University of California San Diego Medical Center where he was subsequently a Clinical Instructor and Assistant Clinical Professor of Medicine from 1995 to 1999. In 1999\, Dr. LoBue joined DTBE as a medical epidemiologist assigned to the Tuberculosis Control Program in San Diego County\, CA. In 2004\, he moved to CDC headquarters in Atlanta\, GA to become Chief of the Medical Consultation Team of DTBE. Between 2006 and 2014\, Dr. LoBue was the Associate Director for Science for the division. Dr. LoBue is a fellow in the American College of Physicians and American College of Chest Physicians. He is also a member of the American Thoracic Society (ATS)\, in which he has served on the Ethics and Conflict of Interest Committee and the Program (chair 2008-2009)\, Planning\, and Executive Committees of the Microbiology\, Tuberculosis\, and Pulmonary Infections Assembly. Dr. LoBue has authored or co-authored more the 80 publications including peer-reviewed journal articles\, book chapters\, and Morbidity and Mortality Weekly Report articles. He has chaired or served on more than 10 guidelines and recommendations committees and panels for multiple organizations including CDC\, ATS\, the US Federal Tuberculosis Task Force\, and the World Health Organization. His scholarly interests include tuberculosis diagnosis\, treatment\, and transmission dynamics\, evidence-based guideline development\, and human subjects research ethics.\n \n If you have any questions or need additional information\, please contact us at 2021hbuteasummit@aapcho.org. \n\nWebinar Resources\nWebinar Slides \nWebinar Recording \nAdditional Resources: \n\nDivision of Viral Hepatitis Strategic Plan\nViral Hepatitis Surveillance Report 2019 – Hepatitis B data  \nAdult Vaccination Resources \nStrategies for Increasing Adult Vaccination Rates \nReported Tuberculosis in the United States\, 2020 \nLatent TB Infection Resource Hub\nTB Centers of Excellence for Training\, Education and Medical Consultation\nTuberculosis Epidemiologic Studies Consortium (TBESC)\nImplementing an Electronic Directly Observed Therapy (eDOT) Program: A Toolkit for Tuberculosis (TB) Programs\nIn-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence
URL:https://tbeliminationalliance.org/event/a-conversation-with-cdc-partners-webinar/
ATTACH;FMTTYPE=image/png:https://tbeliminationalliance.org/wp-content/uploads/2021/12/FINAL-A-Conversation-with-CDC-Partners-Webinar-TW.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220203T123000
DTEND;TZID=America/Los_Angeles:20220224T140000
DTSTAMP:20211217T205658Z
CREATED:20211216T000940Z
LAST-MODIFIED:20211217T205658Z
UID:838-1643891400-1645711200@tbeliminationalliance.org
SUMMARY:"Quality Improvement Strategies for Latent Tuberculosis Infection (LTBI) Screening\, Testing\, and Treatment in Asian/Asian American (A/AA) & Native Hawaiian/Pacific Islander (NH/PI)-Serving Health Centers: Electronic Health Record (EHR) Template Development" Learning Collaborative
DESCRIPTION:The Tuberculosis (TB) Elimination Alliance (TEA) invites you to submit your application to the  TB Learning Collaborative\, “Quality Improvement Strategies for Latent Tuberculosis Infection (LTBI) Screening\, Testing\, and Treatment in Asian/Asian American (A/AA) & Native Hawaiian/Pacific Islander (NH/PI)-Serving Health Centers: Electronic Health Record (EHR) Template Development”. EHR plays a critical role in optimizing the latent TB infection care cascade\, and the Learning Collaborative will highlight clinical experts in this area. \nThe Learning Collaborative consists of four sessions on Thursdays in February from 10:30am-12:00pm HT / 12:30-2:00pm PT/ 3:30-5:00pm ET.  \nDates  \n\nSession 1 – Thursday\, February 3\, 2022 \nSession 2 – Thursday\, February 10\, 2022\nSession 3 – Thursday\, February 17\, 2022\nSession 4 – Thursday\, February 23\, 2022 \n\nAfter this Learning Collaborative\, participants will be able to: \n\nDiscuss challenges and barriers around EHR modification and template development for LTBI screening\, testing\, and treatment;\nIdentify tools to understand and implement EHR templates for LTBI screening\, testing\, and treatment; and \nDevelop a roadmap for EHR template development processes for LTBI screening\, testing\, and treatment.\n\nIntended Participants: Health centers\, health center look-alikes\, and other community health organizations interested and/or invested in TB/LTBI screening\, testing\, and treatment. Health centers and health center look-alikes will be prioritized for selection. An honorarium will be made available for Community Health Center providers and staff participating.  \nFee: No cost/free \nCommitment: Accepted Learning Collaborative applicants are asked to attend a total of four learning sessions in February 2022. Sessions include interactive activities\, small breakout room discussions\, and presentations by subject matter experts. \nApplication Deadline: Friday\, January 21 by 5pm local time \nApply at https://bit.ly/TBEHR-Application\nIf you have trouble accessing the registration link\, visit https://www.surveymonkey.com/r/JMWDK8S. \nHave questions? Please email tea@aapcho.org.  \nFunder: This Learning Collaborative is supported by the Centers for Disease Control & Prevention and the Health Resources & Services Administration.
URL:https://tbeliminationalliance.org/event/quality-improvement-strategies-for-latent-tuberculosis-infection-ltbi-screening-testing-and-treatment-in-asian-asian-american-a-aa-native-hawaiian-pacific-islander-nh-pi-serving-health-cen/
ATTACH;FMTTYPE=image/png:https://tbeliminationalliance.org/wp-content/uploads/2021/12/TB-LC-EHR-February-2022.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230406T120000
DTEND;TZID=America/Los_Angeles:20230427T133000
DTSTAMP:20230313T182425Z
CREATED:20230302T144619Z
LAST-MODIFIED:20230313T182425Z
UID:1175-1680782400-1682602200@tbeliminationalliance.org
SUMMARY:"Quality Improvement Strategies for Latent Tuberculosis Infection (LTBI) Screening\, Testing\, and Treatment in Asian/Asian American (A/AA) & Native Hawaiian/Pacific Islander (NH/PI)-Serving Health Centers: National Clinical Quality Measure Development” Learning Collaborative
DESCRIPTION:The Tuberculosis (TB) Elimination Alliance (TEA) invites you to submit your application to the TB Learning Collaborative\, “Quality Improvement Strategies for Latent Tuberculosis Infection (LTBI) Screening\, Testing\, and Treatment in Asian/Asian American (A/AA) & Native Hawaiian/Pacific Islander (NH/PI)-Serving Health Centers: National Clinical Quality Measure Development” to gain in-depth knowledge and best practices on how to empower patients at health centers through strategies that effectively address LTBI/TB prevention and quality improvement approaches in their communities.  \nThe Learning Collaborative consists of four sessions on Thursdays in April from 9:00am-10:30am HT / 12:00-1:30pm PT/ 3:00-4:30pm ET.  \nSessions and Dates: \n\nApril 6\, 2023 | Session 1 – Background on TB Prevention | April 6\, 2023\nApril 13\, 2023 | Session 2 – Engaging and Supporting Patients with Latent TB Infection (Screening\, Testing and Treatment) \nApril 20\, 2023 | Session 3 – Providing Care for Patients with Latent TB Infection\nApril 27\, 2023 | Session 4 – Latent TB Infection Care Cascade (Measurement\, Barriers and Interventions)\n\nLearning Objectives: \nUpon completion of this training\, participants will be able to: \n\nExplain the importance of tuberculosis prevention and its contribution to overall goals of TB elimination\nDescribe easy-to-use tools and other resources to engage and encourage patients during LTBI treatment to improve care cascade outcomes\nIdentify how to measure the steps in the LTBI care cascade to advocate and reduce preventable losses in the cascade to improve program performance\nIdentify strategies to overcome barriers to each step in the LTBI care cascade to successfully implement and improve patient diagnosis and treatment\n\n\nIntended Participants: Health centers\, Primary Care Associations (PCAs)\, Health Center Controlled Networks (HCCN)\, and community organizations interested and/or invested in LBTI/TB prevention and management with a goal of improving LTBI care and outcomes for their patient population (s). Additional participants may include\, but are not limited to: health care providers\, primary care clinic directors\, health system leaders\, electronic medical record analysts\, and/or public health department leaders providing guidance for primary care settings. An honorarium will be made available for participants from qualifiying community health centers and speakers participating. \nCME/CEUs:  \nThe Curry International Tuberculosis Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This training is approved for up to 9.00 continuing education hours. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Curry International Tuberculosis Center and the Association of Asian Pacific Community Health Organizations (AAPCHO). The Curry International Tuberculosis Center designates this educational activity for up to 9.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.   \nThe Curry International Tuberculosis Center is approved as a provider of continuing education by the California State Board of Registered Nurses\, Provider Number CEP 12308. This training is approved for up to 9.00 continuing education hours. Board requirements prevent us from offering CE credit to people who arrive more than 15 minutes after the start of the training\, or leave the training early. Therefore\, partial credit will not be awarded.  \nFee: No cost/free \nCommitment: Accepted Learning Collaborative applicants are asked to attend a total of four learning sessions in April 2023 as well as complete an evaluation and follow-up evaluation. Sessions include interactive activities\, small breakout room discussions\, and presentations by subject matter experts. \nApplication Deadline: \nWednesday\, March 22\, 2023 by 5:00 pm local time\nApply at bit.ly/3KSnVj8 \nIf you have trouble accessing the registration link\, visit https://www.surveymonkey.com/r/WJNB2Z6. \nHave questions? Please email tea@aapcho.org.  \nFunder: This Learning Collaborative is supported by the Centers for Disease Control & Prevention and the Health Resources & Services Administration. \nPartner: This Learning Collaborative is sponsored by the Association of Asian Pacific Community Health Organizations is co-sponsored by The Curry International Tuberculosis Center.
URL:https://tbeliminationalliance.org/event/tblc2023/
CATEGORIES:Trainings
ATTACH;FMTTYPE=image/png:https://tbeliminationalliance.org/wp-content/uploads/2023/03/TB-LC-NCQMD-April-2023-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230420T120000
DTEND;TZID=America/Los_Angeles:20230420T133000
DTSTAMP:20230330T220803Z
CREATED:20230313T181400Z
LAST-MODIFIED:20230330T220803Z
UID:1200-1681992000-1681997400@tbeliminationalliance.org
SUMMARY:Special Webinar Session of TB Learning Collaborative "Quality Improvement Strategies for Latent Tuberculosis Infection (LTBI) Screening\, Testing\, and Treatment in Asian/Asian American (A/AA) & Native Hawaiian/Pacific Islander (NH/PI)-Serving Health Centers: National Clinical Quality Measure Development - Providing Care for Patients with LTBI"
DESCRIPTION:What are behind the gaps in LTBI/TB prevention and what can health centers and other organizations do to support A/AA and NH/PI patients with LTBI? \nJoin AAPCHO to gain in-depth knowledge and best practices on how to empower patients at health centers through strategies that effectively address LTBI/TB prevention and quality improvement approaches in A/AA and NH/PI communities. \nSpecial Public Webinar Session: Providing Care for Patients with LTBI \nThis webinar session will highlight provider and patient resources for clinical monitoring of patients during LTBI treatment. \nSpeaker: Shereen Katrak\, MD\, MPH\, Medical Officer\, Director\, TB Free California\, Tuberculosis Control Branch\, California Department of Public Health \nDate and Time: Thursday\, April 20\, 2023 from 9:00am-10:30am HT / 12:00-1:30pm PT/ 3:00-4:30pm ET \nPlease note that this registration form is to register as an attendee for our special public webinar session of our 2023 TB Learning Collaborative that will be available to the public to attend on April 20th. If you are interested in applying to be a part of the full four-part series of the 2023 TB Learning Collaborative\, please apply by March 22nd\, 2023\, here.  \nLearning Objectives: \nUpon completion of this training\, participants will be able to: \n\nExplain the importance of tuberculosis prevention and its contribution to overall goals of TB elimination\nDescribe easy-to-use tools and other resources to engage and encourage patients during LTBI treatment to improve care cascade outcomes\nIdentify how to measure the steps in the LTBI care cascade to advocate and reduce preventable losses in the cascade to improve program performance\nIdentify strategies to overcome barriers to each step in the LTBI care cascade to successfully implement and improve patient diagnosis and treatment\n\nIntended Participants: Health centers\, Primary Care Associations (PCAs)\, Health Center Controlled Networks (HCCN)\, and community organizations interested and/or invested in LBTI/TB prevention and management. Additional users may include\, but are not limited to: health care providers\, primary care clinic directors\, health system leaders\, electronic medical record analysts\, and/or public health department leaders providing guidance for primary care settings. \nCME/CEUs will be provided by the Curry International Tuberculosis Center for full participation in the Learning Collaborative ONLY for accepted Learning Collaborative applicants. CME/CEUs will not be provided for this one special session. \nFee: No cost/free \nRegistration Deadline: \nWednesday\, April 13\, 2023 by 5:00 pm local time\nRegister at https://bit.ly/3JanLBf \nIf you have trouble accessing the registration link\, visit https://www.surveymonkey.com/r/2BDW856. \nHave questions? Please email tea@aapcho.org.  \nFunder: The TB Learning Collaborative is supported by the Centers for Disease Control & Prevention and the Health Resources & Services Administration. \nPartner: The TB Learning Collaborative is sponsored by the Association of Asian Pacific Community Health Organizations is co-sponsored by The Curry International Tuberculosis Center.
URL:https://tbeliminationalliance.org/event/tblc2023webinar/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/png:https://tbeliminationalliance.org/wp-content/uploads/2023/03/Copy-of-TB-LC-April-20-Session-ONLY-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20231108T090000
DTEND;TZID=America/Los_Angeles:20231109T130000
DTSTAMP:20231107T205405Z
CREATED:20231031T221501Z
LAST-MODIFIED:20231107T205405Z
UID:1684-1699434000-1699534800@tbeliminationalliance.org
SUMMARY:2023 TB Elimination Alliance Summit
DESCRIPTION:Since its inception in 2019\, TEA distributed over $800\,000 in mini-grant funding to 36 community health organizations. TEA’s Mini-Grant Program funds community-centered projects serving Asian\, Asian American\, Native Hawaiian\, and Pacific Islander\, Hispanic/Latino\, and African American communities that are disproportionately impacted by TB. \nTEA looks forward to building on the progress made so far towards TB elimination by inviting you to join the 2023 TEA virtual summit on November 8-9\, 2023. This exciting event will take place via Zoom from 7:00am-11:00am HT / 9:00am-1:00pm PT / 12:00-4:00pm ET. \nThis year’s summit will focus on the theme “Building Healthy Communities Free of TB”\, showcasing TEA’s Mini-Grant Program. Health center staff\, community leaders\, and other TB leaders are invited to listen in and participate in conversations focused on the exceptional innovations from diverse communities and their collaborative efforts toward achieving health equity over the past five years. \nOver the span of two days at the virtual summit\, participants will hear discussions on lessons learned and promising practices from our communities on the impact of TEA’s mini-grants. Together\, we can build healthy and resilient communities free of TB. \nRegister Here \nSummit Agenda
URL:https://tbeliminationalliance.org/event/2023-tb-elimination-alliance-summit/
CATEGORIES:Events
ATTACH;FMTTYPE=image/png:https://tbeliminationalliance.org/wp-content/uploads/2023/10/2023-TEA-Summit-1-e1699390369420.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260311T140000
DTEND;TZID=America/Los_Angeles:20260311T153000
DTSTAMP:20260311T162746Z
CREATED:20260129T071414Z
LAST-MODIFIED:20260311T162746Z
UID:2076-1773237600-1773243000@tbeliminationalliance.org
SUMMARY:Webinar: Community Power in TB Response — Lessons from the Kansas Outbreak
DESCRIPTION:Join the TB Elimination Alliance\, Association of Asian Pacific Community Health Organizations\, Mayo Clinic Center for Tuberculosis\, and National Tuberculosis Coalition of America as they examine the Kansas experience to highlight how collaboration\, trust-building\, and aligned public health efforts can strengthen TB response and inform elimination work beyond a single jurisdiction. \nThis webinar will highlight the critical impact of community leadership and engagement during the Kansas TB outbreak. It will showcase how grassroots initiatives — driven by trusted community partners and members — are essential for building trust\, encouraging participation\, and shaping an effective response. \nThe discussion will also examine how state and local health departments\, federal agencies\, and national organizations can complement community-led efforts to ensure successful TB testing\, treatment\, and ongoing care. \nSpeakers will share practical lessons\, locally informed strategies\, and insights on strengthening partnerships between communities and government agencies — providing approaches that inform TB elimination efforts nationwide. \nRegister Here
URL:https://tbeliminationalliance.org/event/kansasoutbreakwebinar/
CATEGORIES:Events
ATTACH;FMTTYPE=image/png:https://tbeliminationalliance.org/wp-content/uploads/2026/01/TEA-MCCT-Webinar-03-11-2026-1080x1080-1-e1769671127926.png
END:VEVENT
END:VCALENDAR